AorTech International Plc (AOR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AorTech International Plc (AOR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3290
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventional cardiology, cardiac rhythm management, orthopedic, plastic surgery, gastroenterological and urological applications. It offers Elast-Eon biostable polyurethanes used in medical devices for long term implantation; ECSil, biomedical polymers for pacing and neurostimulation leads, spinal disc, and breast implant; and Elast-Eon reaction injection molding (RIM) products. The company manufactures and distributes Elast-Eon materials through Biomerics LLC. AorTech is headquartered in Surrey, Scotland, the UK.

AorTech International Plc (AOR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AorTech International Plc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
AorTech International Raises USD0.7 Million in Private Placement of Shares 10
AorTech International to Raise USD2.3 Million in Private Placement of Shares 12
AorTech International to Raise USD0.5 Million in Rights Offering of Shares 13
AorTech International Plc – Key Competitors 14
AorTech International Plc – Key Employees 15
AorTech International Plc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Jul 20, 2018: AorTech International: Final results for the year ended 31 March 2018 17
Dec 11, 2017: AorTech International:Unaudited Interim Results For the six months ended 30 September 2017 21
Aug 16, 2017: AorTech International: Audited results for the year ended 31 March 2017 24
Legal and Regulatory 26
Nov 20, 2017: AorTech International: Settlement of Litigation 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
AorTech International Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AorTech International Raises USD0.7 Million in Private Placement of Shares 10
AorTech International to Raise USD2.3 Million in Private Placement of Shares 12
AorTech International to Raise USD0.5 Million in Rights Offering of Shares 13
AorTech International Plc, Key Competitors 14
AorTech International Plc, Key Employees 15
AorTech International Plc, Subsidiaries 16

List of Figures
AorTech International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[AorTech International Plc (AOR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chuo Kagaku Co., Ltd.:企業の戦略・SWOT・財務情報
    Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alamos Gold Inc.:企業の戦略・SWOT・財務情報
    Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Repligen Corp (RGEN):企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) operates as a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS …
  • Meredith Corporation:企業の戦略・SWOT・財務分析
    Meredith Corporation - Strategy, SWOT and Corporate Finance Report Summary Meredith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Baltimore Gas and Electric Company:発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Macquarie Group Ltd:戦略・SWOT・企業財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sempra U.S. Gas & Power LLC-石油・ガス分野:企業M&A・提携分析
    Summary Sempra U.S. Gas & Power, LLC (Sempra US), a subsidiary of Sempra Energy, an energy solution provider, is a clean power solutions developer. It develops, designs, constructs and operates renewable energy and natural gas solutions, with a focus on zero and low emission fuels. The company owns …
  • Sino Hotels (Holdings) Limited
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析
    Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • HeidelbergCement AG:企業のM&A・事業提携・投資動向
    HeidelbergCement AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HeidelbergCement AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Panhandle Oil and Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Panhandle Oil and Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oi …
  • Quantum Fuel Systems LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Fuel Systems LLC (Quantum) is a provider of natural gas storage systems, integration and vehicle system technologies. The company produces advanced and lightweight compressed natural gas (CNG) storage tanks and fully integrated natural gas storage systems and supplies these tanks to …
  • Iroko Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Iroko Pharmaceuticals LLC (Iroko) is a specialty pharmaceutical company that develops and commercializes pharmaceutical products. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of noncli …
  • Seven Generations Energy Ltd (VII):石油・ガス:M&Aディール及び事業提携情報
    Summary Seven Generations Energy Ltd (7G) is an independent oil and gas exploration and development company that acquires, develops and explores natural gas resource plays for the production of natural gas in Canada. The company holds interests in the Alberta Deep Basin located in the south of Grand …
  • Vectura Group Plc (VEC)-医療機器分野:企業M&A・提携分析
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆